Plant-Based Vaccines Market is expected to reach US$ 2,672.05 Million by 2028

PRESS RELEASE BY The Insight Partners 16 Nov 2021

Share this press on

Bacterial Vaccines Segment to Lead Plant-Based Vaccines Market During 2021–2028


According to our new research study on "Plant-Based Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Vaccine Type, Source, Application, and Geography," the market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021; it is expected to grow at a CAGR of 12.9% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to increasing research & development (R&D) activities and the growing prevalence of infectious diseases. However, the potential risk of contamination and environmental risks of manufacturing the vaccines are likely to hamper the market's growth in the coming years.


Based on vaccine type, the plant-based vaccines market is segmented into bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles (VLPS), and others. The bacterial vaccines segment held the largest share of the market in 2021. However, the plant-derived virus-like particles (VLPs) segment is anticipated to register the highest CAGR in the market during the forecast period. Bacterial vaccines may contain live bacteria that are attenuated, inactivated, or killed. Bacterial vaccines are categorized into toxoids, subunit vaccines, killed whole-cell vaccines, and live attenuated vaccines. Toxoids are chemically inactivated toxins from bacteria such as Corynebacterium diphtheria. The subunit vaccines consist only of a single antigen of the pathogen. For a subunit, the immune response is lower than a whole cell. The inactivated vaccines contain killed bacterial cells that are inactivated through chemical, heat, or radiation treatment of the disease-causing bacteria. Live vaccines are attenuated living bacteria. Attenuation can be achieved through spontaneous or targeted mutation of various genes essential for virulence; an example is the Ty21a typhoid vaccine. The major pathogens of plants are parasitic plants, and bacteria including bacterial Pseudomonas syringea pv. that causes necrotic lesions surrounded by yellow chlorotic halos on tomatoes. It reduces yields, and affects fruit quality.


Impact of COVID-19 Pandemic on plant-based vaccines market:

The COVID-19 pandemic is adversely affecting industries worldwide. The outbreak led to significant disruptions in primary industries, such as manufacturing, healthcare, energy & power, electronics & semiconductor, aerospace & defense, and construction in 2020. In response to the need to control the spread of the COVID-19 infection among people, hospitals discontinued several services and redirected their operations toward the management of the disease. Moreover, hospitals and healthcare providers has to reassign their specialist doctors to various tasks in ICUs and other COVID-19-related wards. Care receivers also avoided visits to clinics for non-lethal conditions in the first and second quarters of 2020. However, due to increasing number of Covid-19 cases, the demand for the development of plant-based vaccines surged and resulted in the growth of the plant-based vaccines market.


MEDICAGO, INC.; British American Tobacco p.l.c.; ICON GENETICS GMBH; CREATIVE BIOLABS, INC.; iBio, Inc.; LENIOBIO; Lumen Bioscience, Inc.; LEAF EXPRESSION SYSTEMS LTD.; ZYUS LIFE SCIENCES INC.; and FRAUNHOFER CMB are among the leading companies in the plant-based vaccines market.

Plant-Based Vaccines Market, by Region, 2021 (%)

Plant-Based Vaccines Market, by Region, 2021 (%)

Plant-Based Vaccines Market Trends and Top Players 2021-2031

Download Free Sample

Plant Based Vaccines Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Plant-derived Virus-like particles (VLPs), Others), Source (Tobacco Plant, Maize, Potato, Others), Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Others), and Geography

The report segments the plant-based vaccines market as follows:

The plant-based vaccines market is segmented based on vaccine type, source, application, and geography. Based on vaccine type, the market is categorized into bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles (VLPs), and others. Based on source, the plant-based vaccines market has been segmented into tobacco plant, maize, potato, and others. Based on application, the Plant-based vaccines market has been segmented into influenza, zika virus, Ebola virus, COVID-19, poultry disease, and others. On the basis of geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East and Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).


Contact Us
Phone: +1-646-491-9876
Email Id:

Download Free PDF Brochure